Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...